Back

Nutriband CEO to attend inaugural Nasdaq LaB Biotech Summit

Verifying
  • Nutriband CEO Gareth Sheridan will attend the inaugural Nasdaq LaB Biotech Summit.
  • September 16 is the scheduled date for the event at Nasdaq MarketSite in New York.
  • AVERSA technology has patents granted across the United States and eight additional markets.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.